A NSCLC-specific analysis indicated the majority (25/33) of ELF3 PPI disruptions occurred in LUAD as compared with LUSC and lung large cell carcinoma (Fig. 5b) prompting a detailed investigation of altered PPIs and pathways in this subtype29. This evidence concerns the gene ELF3 and non-small cell lung carcinoma.